Browse
Submit Data
Databases
API
Help

Dataset Information

37 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Irish Thoracic Society Annual Scientific Meeting 2020.

ABSTRACT:

SUBMITTER:

PROVIDER: S-EPMC7788179 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Similar Datasets

Proceedings of the Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting 2020.

Project description: Not available

| S-EPMC8009688 | biostudies-literature

36th Annual Scientific Meeting of the Canadian Pain Society: Abstracts

Project description:A full-text version of the abstracts to be presented at the 36th Annual Scientific Meeting of the Canadian Pain Society is published online only. To view the full-text abstracts, go to www.pulsus.com

| S-EPMC4447163 | biostudies-literature

Proceedings of the Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting 2019

Project description: Not available

| S-EPMC7313110 | biostudies-literature

Proceedings of the Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting 2018

Project description: Not available

| S-EPMC6399812 | biostudies-literature

American Society of Hematology 2015 Annual Meeting.

Project description:The annual meeting of the American Society of Hematology drew 25,000 attendees for the presentation of 5,633 abstracts. We review key sessions focusing on newer agents and their efficacy in high-risk leukemia and multiple myeloma populations.

| S-EPMC4745640 | biostudies-literature

Major advances in the treatment of multiple myeloma in American Society of Hematology annual meeting 2020

Project description:Treatment of multiple myeloma (MM) has advanced dramatically in the past two decades. However, under the conditions of the COVID-19 pandemic, treatment strategies have been modified accordingly. Numerous novel agents, updated trials, and major advances in myeloma have been reported in the American Society of Hematology 2020 annual meeting, either for transplant-eligible or ineligible patients. Hot topics such as the significance of autologous stem cell transplantation (ASCT), development of novel agents, and chimeric antigen receptor-T (CAR-T) cells have been widely discussed. The triplet regimen bortezomib, lenalidomide, and dexamethasone (VRd) is recommended as the standard first-line treatment, and the addition of a fourth drug improves efficacy and survival. The value of ASCT remains undoubtful, even in the era of quadruplet induction. Dual-drug maintenance, including proteasome inhibitors and immunomodulatory drugs, overcomes unfavorable outcomes in high-risk patients. For relapsed/refractory myeloma (RRMM) patients, novel agents such as selinexor and venetoclax are superior. CAR-T cells and other cell-surface-targeted therapies also appear promising.

| S-EPMC8579022 | biostudies-literature

Abstracts for the 2021 TSANZ Annual Scientific Meeting

Project description: Not available

| S-EPMC8109145 | biostudies-literature

25th Annual Meeting of the German Society of Newborn Screening.

Project description:From 15-16 June 2018, the 25th Annual Meeting of the German Society for Newborn Screening (Deutsche Gesellschaft für Neugeborenenscreening, DGNS) was held at the Van Swieten Hall of the Medical University of Vienna, Vienna, Austria. For the first time, this annual meeting was held outside Germany and organized by Maximilian Zeyda, PhD and Vassiliki Konstantopoulou, MD (conference presidents), directors of the Austrian Newborn Screening located at the Dept. of Pediatrics at the Medical University of Vienna. A local scientific board formed by Maximilian Zeyda and Vassiliki Konstantopoulou selected presentations from abstracts that were submitted by scientists of 7 countries, highlighting one purpose of this meeting, which was to foster contact and exchange of newborn screening labs of central European countries. Abstracts of invited lectures, oral communications, and posters presented during the meeting are collected in this report.

| S-EPMC7510186 | biostudies-literature

The society for craniofacial genetics and developmental biology 38th annual meeting.

Project description:The mission of the Society for Craniofacial Genetics and Developmental Biology (SCGDB) is to promote education, research, and communication about normal and abnormal development of the tissues and organs of the head. The SCGDB welcomes as members undergraduate students, graduate students, post doctoral researchers, clinicians, orthodontists, scientists, and academicians who share an interest in craniofacial biology. Each year our members come together to share their novel findings, build upon, and challenge current knowledge of craniofacial biology. © 2016 Wiley Periodicals, Inc.

| S-EPMC5880526 | biostudies-literature

Abstracts from the 2017 Society of General Internal Medicine Annual Meeting.

Project description: Not available

| S-EPMC5391321 | biostudies-literature